Related Experiment Video
Updated: Aug 12, 2026
08:42
Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
Published on: October 22, 2014
Sympathetic activation markedly reduces endothelium-dependent, flow-mediated vasodilation
Michel L Hijmering1, Erik S G Stroes, Jobien Olijhoek
1Department of Internal Medicine, Eemland Hospital, Amersfoort, The Netherlands.
Journal of the American College of Cardiology
|February 19, 2002
Summary
Increased sympathetic nervous system activity impairs flow-mediated dilation (FMD), a key measure of endothelial function. This effect is mediated by alpha-adrenergic mechanisms, suggesting a link between sympathetic tone and vascular health.
Area of Science:
- Cardiovascular Physiology
- Vascular Biology
- Autonomic Nervous System Function
Background:
- Endothelial function, measured by flow-mediated dilation (FMD), is a critical indicator in cardiovascular research.
- Many conditions associated with heightened sympathetic tone also exhibit endothelial dysfunction.
Purpose of the Study:
- To investigate the impact of increased sympathetic outflow on flow-mediated dilation (FMD).
- To determine the specific mechanism, particularly the role of alpha-adrenergic pathways, in this interaction.
Main Methods:
- Healthy volunteers underwent FMD assessments with and without sympathetic stimulation induced by baroreceptor unloading.
- Endothelium-independent vasodilation was measured using intra-arterial nitroglycerin (NTG).
- Alpha-adrenergic blockade was achieved using phentolamine (PE) in a subset of participants.
Main Results:
- Sympathetic stimulation significantly reduced FMD responses by over 50% (p < 0.01).
- Alpha-adrenergic blockade with phentolamine abolished the FMD attenuation caused by sympathetic stimulation.
- Nitroglycerin-induced vasodilation remained unaffected, indicating the effect was specific to FMD.
Conclusions:
- Clinically relevant levels of sympathetic stimulation significantly impair FMD.
- This impairment is primarily mediated through an alpha-adrenergic mechanism.
- Findings highlight a direct link between sympathetic overactivity and endothelial dysfunction.
More Related Videos
Related Concept Videos
01:28Nitric Oxide Signaling Pathway
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
01:17Antihypertensive Drugs: Action of β1 Blockers
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
01:18Antihypertensive Drugs: Action of Calcium Channel Blockers
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:16Vascular Spasm
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
01:17Autoregulation of Blood Flow
Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.